Hot Biotech Stocks to Watch (MNTA, CGEN, XOMA, BTIM)

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) soared 68% to $19.93. The stock is trading higher on news that the FDA has confirmed approval for the first generic Lovenox. In a recent press release, the company “confirms that the FDA has granted marketing approval of the Abbreviated New Drug Application (ANDA) for enoxaparin sodium for injection filed by Sandoz.”

Compugen Ltd. (USA) (NASDAQ:CGEN) extended its weekly gains and rose 5.20%. Compugen Ltd. (Compugen) is an early-stage drug and diagnostic discovery company. The Company’s business is focused on developing and using computer-based discovery platforms to discover therapeutic drug candidates and diagnostic biomarker candidates. It uses experimental biological processes to validate product candidates discovered by its predictive platforms.

XOMA Limited (NASDAQ:XOMA) fell 6.06% to $0.338 with over 1.52 million shares. XOMA Ltd. (XOMA) is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies designed to treat inflammatory, autoimmune, infectious and oncological diseases.

BioTime, Inc. (AMEX:BTIM) is one of the most unusual mover and rose 2.10% to $5.35 with over 116K.  BioTime, Inc. is a biotechnology company engaged in two areas of biomedical research and product development.